GlassScriptPhysician profile
Brandi M Wiens
NPI 1962848085
$2,906.92
in general payments reported to CMS, 2019-2025
40 companies · $1,655 in 2025
The $1,655 reported for 2025 was more than what 92% of Adult Medicine providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.69 · 2020: $110 · 2021: $208 · 2022: $123 · 2023: $80.85 · 2024: $701 · 2025: $1,655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,436.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $318.50 | 2024-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $272.17 | 2021-2025 | |
| Novo Nordisk INC | $256.75 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $232.78 | 2019-2025 | Evenity, Otezla, Repatha |
| Trice Medical, INC. | $194.90 | 2024 | |
| Vanda Pharmaceuticals INC. | $136.51 | 2024-2025 | Fanapt, Hetlioz |
| Bayer Healthcare Pharmaceuticals INC. | $133.05 | 2024-2025 | |
| Lilly USA, LLC | $129.17 | 2025 | Zepbound, Mounjaro, Kisunla |
| Glaxosmithkline, LLC. | $108.73 | 2019-2025 | Trelegy Ellipta, Arexvy, Bexsero |
| Abbvie INC. | $106.94 | 2020-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $102.87 | 2024-2025 | Xifaxan |
| Otsuka America Pharmaceutical, INC. | $89.80 | 2024-2025 | Rexulti |
| Lundbeck LLC | $68.52 | 2024-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $60.63 | 2021-2024 | Gardasil 9, Vaxneuvance, Gardasil |
| Verona Pharma, INC. | $58.84 | 2025 | Ohtuvayre |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandi Wiens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.